Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Brinavess 20 mg/ml concentrate for solution for infusion

Active Ingredient:
vernakalant hydrochloride
Company:  
ADVANZ Pharma See contact details
ATC code: 
C01BG11
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Appropriate use of Brinavess

{healthcare_pro_orange} For Healthcare Professionals

Appropriate use of Brinavess (vernakalant hydrochloride) concentrate for solution for infusion

{pdf_link}

Brinavess Pre-infusion Checklist

{healthcare_pro_orange} For Healthcare Professionals

Prior to administration the prescriber is asked to determine eligibility of the patient through use of the supplied checklist. The checklist should be placed on the infusion container to be read by the healthcare professional who will administer BRINAVESS.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

ADVANZ Pharma
Company image
Address
Dashwood House, 69 Old Broad Street, London, EC2M 1QS, UK
WWW
www.advanzpharma.com
Telephone
+44 (0)208 588 9131
Medical Information Direct Line
+44 (0)208 588 9131
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)208 588 9273